Shilbayeh Sireen
Faculty of Pharmacy, Al-Zytoona University, PO Box 130, 11733 Amman, Jordan.
Osteoporos Int. 2003 Nov;14(11):929-40. doi: 10.1007/s00198-003-1458-4. Epub 2003 Oct 7.
Extensive differences in the osteoporosis epidemiological pattern among geographic and ethnic groups have been reported. The evidence concerning association of multiple pregnancies, lactations, and other menstrual history factors with low bone mineral density (BMD) remains inconclusive. Previous local studies addressing these issues in Jordan are very restricted. We present a cross-sectional study of Jordanian women who visited outpatient clinics between August 2000 and August 2002 at two community hospitals in Amman City. BMD measurement was performed for all subjects, while comprehensive appraisal of clinical issues related to reproductive status and past medical history was carried out using a structured questionnaire administered to 50% of the subjects. We also attempted to examine the current hypothesis of possible influence of hyperlipidemia and thyroid abnormalities on decreased BMD. According to WHO criteria, 119 (29.6%) were identified as having osteoporosis, 176 (43.8%) were osteopenic, and 107 (26.6%) had normal BMD. The multiple-linear regression analyses at different bone sites revealed that age, years of menopause, low-density lipoprotein (LDL), and follicle-stimulating hormone (FSH) have strong independent associations with decreased BMD at all lumbar and femoral neck regions. The negative effect associated with number of children (live births) and frequency of lactations was only evident at femoral neck. Although years of menstruation, age at menopause, days of menstrual cycle, number of pregnancies, and duration of hormone replacement therapy (HRT) were positively correlated with BMD, they had weaker associations than previous variables. Moreover, in the final multivariable logistic regression model, variables which rendered significantly independent risk factors after adjustment for age and BMI were: current smokers of more that 25 cigarettes/day, postmenopausal women irrespective of HRT use, menopausal years of > or =5 year intervals, natural early menopause, gastrointestinal disease, rheumatoid arthritis, osteoarthritis, hypertension, and thyroid replacement therapy. Ever-lactation, frequent lactation of 4 or more times, duration of lactation interval of 1-6 months and clinical hyperthyroidism were significant protective factors. Hysterectomy with or without oophorectomy, premature ovarian failure, gravidity, menstrual flow pattern, family history of osteoporosis, clinical hypothyroidism, hyperlipidemia, HRT, and corticosteroids therapy were not independent predictors of osteoporosis among our population. It was concluded that the prevalence of this worldwide public health problem among the Jordanian female population is extremely high, and is even found in younger age categories compared to previous international surveys. Though, the number of pregnancies in our multiparous female population showed a negative impact on femoral neck BMD, no evidence of increased risk of osteoporosis among ever-pregnant women was noted. Conversely, the current data analysis highlight many potential risk factors including associated medical illnesses, and other hormonal alterations experienced during menopausal period. Therefore, increased health awareness and intensive screening programs are mandatory for early detection of low bone mass.
据报道,不同地理和种族群体的骨质疏松症流行病学模式存在广泛差异。关于多次怀孕、哺乳及其他月经史因素与低骨密度(BMD)之间关联的证据尚无定论。此前约旦针对这些问题的本地研究非常有限。我们开展了一项横断面研究,研究对象为2000年8月至2002年8月期间在安曼市两家社区医院门诊就诊的约旦女性。对所有受试者进行了骨密度测量,同时使用结构化问卷对50%的受试者进行了与生殖状况和既往病史相关的临床问题综合评估。我们还试图检验当前关于高脂血症和甲状腺异常对骨密度降低可能产生影响的假说。根据世界卫生组织标准,119人(29.6%)被确定患有骨质疏松症,176人(43.8%)骨质减少,107人(26.6%)骨密度正常。不同骨部位的多元线性回归分析显示,年龄、绝经年限、低密度脂蛋白(LDL)和促卵泡激素(FSH)与所有腰椎和股骨颈区域的骨密度降低均有强烈的独立关联。与子女数量(活产数)和哺乳频率相关的负面影响仅在股骨颈处明显。尽管月经年限、绝经年龄、月经周期天数、怀孕次数和激素替代疗法(HRT)持续时间与骨密度呈正相关,但其关联强度低于先前的变量。此外,在最终的多变量逻辑回归模型中,在调整年龄和体重指数后呈现出显著独立危险因素的变量有:每天吸烟超过25支的当前吸烟者、无论是否使用HRT的绝经后女性、绝经间隔≥5年、自然早绝经、胃肠道疾病、类风湿关节炎、骨关节炎、高血压以及甲状腺替代疗法。曾经哺乳、哺乳4次或更多次、哺乳间隔持续时间为1 - 6个月以及临床甲状腺功能亢进是显著的保护因素。子宫切除术(无论是否同时切除卵巢)、卵巢早衰、妊娠次数、月经流量模式、骨质疏松症家族史、临床甲状腺功能减退、高脂血症、HRT和皮质类固醇疗法在我们的研究人群中并非骨质疏松症的独立预测因素。研究得出结论,这一全球公共卫生问题在约旦女性人群中的患病率极高,与以往国际调查相比,在更年轻的年龄段也有发现。尽管我们多产女性人群中的怀孕次数对股骨颈骨密度有负面影响,但未发现曾怀孕女性骨质疏松症风险增加的证据。相反,当前的数据分析突出了许多潜在危险因素,包括相关的内科疾病以及绝经期间经历的其他激素变化。因此,提高健康意识和加强筛查项目对于早期发现低骨量至关重要。